Table 1. Clinical and immunophenotypic... | American Society of Hematology

Table 1.

Clinical and immunophenotypic characteristics of leukemic patients

Sample ID	Age, y	Leukemia type	Sample type	Cytogenetics	% Blasts	% Blasts
Sample ID	Age, y	Leukemia type	Sample type	Cytogenetics	% Blasts	CD34⁺	CD38⁺	CD105⁺
P0001	3	ALL–B cell	BM	t(12;21) TEL/AML1	98	3.60	99.70	99
P0012	4	ALL–B cell	BM	+x,+6,+14,+17,+18,+21,+21 hyperdiploid (54)	97	95	100.00	92.60
P0016	5	ALL–B cell	BM	Trisomy 21	99	98	70.80	98.30
P0019	16	ALL–B cell	BM	t(9;22)	98	96.60	44.70	98.30
P0028	1	ALL–B cell	Apheresis	dic(9;20)	98	99.60	99.70	96.60
P0021	12	AML	Apheresis	+6 FLT3pos	91	88	95	65
A0032	66	AML	PB	t(1;3)del(5),−7,idem,t(1;17); CML transformed to AML; prior dx of MDS	88.50	99.80	7.63	98.50
A0036	49	AML	Apheresis	Normal	87	0.01	97.80	47.60
A0050	86	AML	BM	Trisomy 8	55.60	88	94.60	74.40

Sample ID	Age, y	Leukemia type	Sample type	Cytogenetics	% Blasts	% Blasts
Sample ID	Age, y	Leukemia type	Sample type	Cytogenetics	% Blasts	CD34⁺	CD38⁺	CD105⁺
P0001	3	ALL–B cell	BM	t(12;21) TEL/AML1	98	3.60	99.70	99
P0012	4	ALL–B cell	BM	+x,+6,+14,+17,+18,+21,+21 hyperdiploid (54)	97	95	100.00	92.60
P0016	5	ALL–B cell	BM	Trisomy 21	99	98	70.80	98.30
P0019	16	ALL–B cell	BM	t(9;22)	98	96.60	44.70	98.30
P0028	1	ALL–B cell	Apheresis	dic(9;20)	98	99.60	99.70	96.60
P0021	12	AML	Apheresis	+6 FLT3pos	91	88	95	65
A0032	66	AML	PB	t(1;3)del(5),−7,idem,t(1;17); CML transformed to AML; prior dx of MDS	88.50	99.80	7.63	98.50
A0036	49	AML	Apheresis	Normal	87	0.01	97.80	47.60
A0050	86	AML	BM	Trisomy 8	55.60	88	94.60	74.40

CML, chronic myeloid leukemia; dx, diagnosis; ID, identification; MDS, myelodysplastic syndrome.